IDEXX LABORATORIES, INC.

(IDXX)
  Report
Delayed Nasdaq  -  04:00 2022-08-08 pm EDT
407.00 USD   -0.19%
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates Overweight Rating
MT
08/05Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overweight Rating
MT
08/04Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IDEXX Laboratories : Earnings, Revenue Rise in Q4, Unveils 2021 Outlook

02/02/2021 | 07:41am EDT


© MT Newswires 2021
All news about IDEXX LABORATORIES, INC.
08/08Piper Sandler Adjusts Price Target on IDEXX Laboratories to $500 From $420, Reiterates ..
MT
08/05Barclays Adjusts Price Target on IDEXX Laboratories to $582 From $700, Reiterates Overw..
MT
08/04Morgan Stanley Lowers IDEXX Laboratories Price Target to $573 From $603, Maintains Over..
MT
08/03Atlantic Equities Adjusts Price Target on IDEXX Laboratories to $490 From $500, Reitera..
MT
08/02IDEXX LABORATORIES INC /DE Management's Discussion and Analysis of Financial Condition..
AQ
08/02WALL STREET STOCK EXCHANGE : Pelosi’s expected Taiwan visit spooks markets
MS
08/02SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Tuesday
MT
08/02TRANSCRIPT : IDEXX Laboratories, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02IDEXX Laboratories Q2 Profit Declines While Revenue Rises; Lowers Full-Year 2022 Outloo..
MT
08/02IDEXX LABORATORIES : Announces Second Quarter Results - Form 8-K
PU
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Financials (USD)
Sales 2022 3 382 M - -
Net income 2022 687 M - -
Net Debt 2022 1 126 M - -
P/E ratio 2022 50,3x
Yield 2022 -
Capitalization 34 191 M 34 191 M -
EV / Sales 2022 10,4x
EV / Sales 2023 9,55x
Nbr of Employees 10 350
Free-Float 77,1%
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 407,00 $
Average target price 477,00 $
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Murthy Yerramilli Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.-38.07%34 191
ABBOTT LABORATORIES-22.37%190 883
MEDTRONIC PLC-9.83%124 341
STRYKER CORPORATION-18.73%82 217
BECTON, DICKINSON AND COMPANY4.15%73 001
HOYA CORPORATION-15.34%38 786